The association between MPL (MPL Proto-Oncogene, Thrombopoietin Receptor) and Essential Thrombocythemia is well established and manually curated, with its 3 contributing sources — 2 of them expert-curated — recording pathogenic variants and causative variation.
Sources3
Clinical variants645
Symptoms46
Compounds0
Trials0
Publications52
01
At a glance
Association overview
A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.